Comparison of immune reconstitution after allogeneic versus autologous stem cell transplantation in 182 patients
Standard
Comparison of immune reconstitution after allogeneic versus autologous stem cell transplantation in 182 patients. / Wiegering, Verena; Eyrich, Matthias; Winkler, Beate; Schlegel, Paul-Gerhardt.
in: J PEDIAT HEMATOL ONC, Jahrgang 41, Nr. 5, 2018, S. e302-e307.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Comparison of immune reconstitution after allogeneic versus autologous stem cell transplantation in 182 patients
AU - Wiegering, Verena
AU - Eyrich, Matthias
AU - Winkler, Beate
AU - Schlegel, Paul-Gerhardt
PY - 2018
Y1 - 2018
N2 - Hematopoietic stem cell transplantation (HSCT) is a life-saving procedure for children with a variety of malignant and nonmalignant conditions. However, even if immune reconstitution after HSCT has been studied extensively, until now, data on the comparison of immune reconstitution after autologous versus allogeneic HSCT are scarce, but might provide important clinical implications. We examined immune reconstitution (T cells, B cells, and NK cells) at defined timepoints in 147 children who received 182 HSCTs. Differences in the time course of immune reconstitution were analyzed in autologous versus allogeneic HSCT. We identified a quicker immune reconstitution in the T-cell compartment, especially in the CD4 and naive subset after autologous HSCT, whereas recipients of allogeneic transplants showed a higher TCRgd proportion. B-cell reconstitution showed a delayed immune reconstitution after allogeneic HSCT in the first 2 years after HSCT. However, a reconstitution of all lymphocyte subsets after HSCT could be achieved in all patients. Children undergoing an HSCT show a different pattern of immune reconstitution in the allogeneic and autologous setting. This might influence the outcome and should affect the clinical handling of infectious prophylaxis and revaccinations.
AB - Hematopoietic stem cell transplantation (HSCT) is a life-saving procedure for children with a variety of malignant and nonmalignant conditions. However, even if immune reconstitution after HSCT has been studied extensively, until now, data on the comparison of immune reconstitution after autologous versus allogeneic HSCT are scarce, but might provide important clinical implications. We examined immune reconstitution (T cells, B cells, and NK cells) at defined timepoints in 147 children who received 182 HSCTs. Differences in the time course of immune reconstitution were analyzed in autologous versus allogeneic HSCT. We identified a quicker immune reconstitution in the T-cell compartment, especially in the CD4 and naive subset after autologous HSCT, whereas recipients of allogeneic transplants showed a higher TCRgd proportion. B-cell reconstitution showed a delayed immune reconstitution after allogeneic HSCT in the first 2 years after HSCT. However, a reconstitution of all lymphocyte subsets after HSCT could be achieved in all patients. Children undergoing an HSCT show a different pattern of immune reconstitution in the allogeneic and autologous setting. This might influence the outcome and should affect the clinical handling of infectious prophylaxis and revaccinations.
KW - Adolescent
KW - Child
KW - Child, Preschool
KW - Female
KW - Hematopoietic Stem Cell Transplantation/methods
KW - Humans
KW - Immune Reconstitution
KW - Lymphocyte Subsets
KW - Male
KW - Time Factors
KW - Transplantation, Autologous/standards
KW - Transplantation, Homologous/standards
U2 - 10.1097/MPH.0000000000001340
DO - 10.1097/MPH.0000000000001340
M3 - SCORING: Journal article
C2 - 30418422
VL - 41
SP - e302-e307
JO - J PEDIAT HEMATOL ONC
JF - J PEDIAT HEMATOL ONC
SN - 1077-4114
IS - 5
ER -